Completed Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma NCT01154452 Conditions Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor, +85 more Locations Memorial Sloan-Kettering Cancer Center — New York, United States View Trial Details
Completed Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer NCT00397384 Conditions Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, +135 more Locations Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States View Trial Details
Completed 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) NCT00031681 Conditions Adenocarcinoma, Adnexal Diseases, Advanced Adult Primary Liver Cancer, +182 more Locations University of Virginia — Charlottesville, Virginia, United States View Trial Details
